| |
 |
ARTICLES 
|
|
| Fluorouracil, interferon-alpha, and colon cancer: rational pursuit of synergism between antimetabolites and biologicals |
| MS Ernstoff, BC Lembersky, and JM Kirkwood |
|
JCO Dec 1 1989: 1764–1765.
[PDF]
|
 |
| How much MOPP? |
| SJ Horning |
|
JCO Dec 1 1989: 1766–1768.
[PDF]
|
|
|
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma |
| |
S Wadler, EL Schwartz, M Goldman, A Lyver, M Rader, M Zimmerman, L Itri, V Weinberg, and PH Wiernik |
| |
JCO Dec 1 1989: 1769–1775.
[Abstract]
[PDF]
|
|
|
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease |
| |
RE van Rijswijk, C Haanen, AW Dekker, AJ de Meijer, and J Verbeek |
| |
JCO Dec 1 1989: 1776–1782.
[Abstract]
[PDF]
|
|
|
Clinical significance of immunophenotype in diffuse aggressive non- Hodgkin's lymphoma |
| |
JO Armitage, JM Vose, J Linder, D Weisenburger, D Harrington, J Casey, P Bierman, S Sorensen, M Hutchins, and DF Moravec |
| |
JCO Dec 1 1989: 1783–1790.
[Abstract]
[PDF]
|
|
|
Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease [published erratum appears in J Clin Oncol 1990 Mar;8(3):567] |
| |
KM Taylor, S Jagannath, G Spitzer, JA Spinolo, SL Tucker, B Fogel, FF Cabanillas, FB Hagemeister, and LM Souza |
| |
JCO Dec 1 1989: 1791–1799.
[Abstract]
[PDF]
|
|
|
High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma |
| |
N Peylan-Ramu, TB Haddy, E Jones, K Horvath, MA Adde, and IT Magrath |
| |
JCO Dec 1 1989: 1800–1806.
[Abstract]
[PDF]
|
|
|
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group |
| |
DR Miller, PF Coccia, WA Bleyer, JN Lukens, SE Siegel, HN Sather, and GD Hammond |
| |
JCO Dec 1 1989: 1807–1815.
[Abstract]
[PDF]
|
|
|
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia [published erratum appears in J Clin Oncol 1990 Mar;8(3):567] |
| |
L Lennard and JS Lilleyman |
| |
JCO Dec 1 1989: 1816–1823.
[Abstract]
[PDF]
|
|
|
High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer |
| |
SF Williams, R Mick, R Desser, J Golick, J Beschorner, and JD Bitran |
| |
JCO Dec 1 1989: 1824–1830.
[Abstract]
[PDF]
|
|
|
Elevated plasma concentrations of C-flanking gastrin-releasing peptide in small-cell lung cancer |
| |
JJ Holst, M Hansen, E Bork, and TW Schwartz |
| |
JCO Dec 1 1989: 1831–1838.
[Abstract]
[PDF]
|
|
|
Prognostic factors in multiple myeloma: definition of risk groups in 410 previously untreated patients: a Grupo Argentino de Tratamiento de la Leucemia Aguda study |
| |
C Corrado, MT Santarelli, S Pavlovsky, and M Pizzolato |
| |
JCO Dec 1 1989: 1839–1844.
[Abstract]
[PDF]
|
|
|
Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience |
| |
TA Alvegard and NO Berg |
| |
JCO Dec 1 1989: 1845–1851.
[Abstract]
[PDF]
|
|
|
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients |
| |
B Fisher, AM Keenan, BS Garra, SM Steinberg, DE White, AM DiBisceglie, JH Hoofnagle, P Yolles, SA Rosenberg, and MT Lotze |
| |
JCO Dec 1 1989: 1852–1862.
[Abstract]
[PDF]
|
|
|
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer |
| |
SA Rosenberg, MT Lotze, JC Yang, WM Linehan, C Seipp, S Calabro, SE Karp, RM Sherry, S Steinberg, and DE White |
| |
JCO Dec 1 1989: 1863–1874.
[Abstract]
[PDF]
|
|
|
Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma |
| |
W Aulitzky, G Gastl, WE Aulitzky, M Herold, J Kemmler, B Mull, J Frick, and C Huber |
| |
JCO Dec 1 1989: 1875–1884.
[Abstract]
[PDF]
|
|
|
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2 |
| |
JC Wang, A Walle, A Novogrodsky, M Suthanthiran, RT Silver, NH Bander, AL Rubin, and KH Stenzel |
| |
JCO Dec 1 1989: 1885–1891.
[Abstract]
[PDF]
|
|
|
A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study |
| |
FB Stehman, JA Blessing, R McGehee, and RJ Barrett |
| |
JCO Dec 1 1989: 1892–1895.
[Abstract]
[PDF]
|
|
|
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide |
| |
CP Belani, MJ Egorin, JS Abrams, D Hiponia, M Eisenberger, J Aisner, and DA Van Echo |
| |
JCO Dec 1 1989: 1896–1902.
[Abstract]
[PDF]
|
|
|
Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients |
| |
G Swanson, J Smith, R Bulich, P New, and R Shiffman |
| |
JCO Dec 1 1989: 1903–1908.
[Abstract]
[PDF]
|
|
|
Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease |
| |
R Bataille, D Chappard, C Marcelli, P Dessauw, J Sany, P Baldet, and C Alexandre |
| |
JCO Dec 1 1989: 1909–1914.
[Abstract]
[PDF]
|
|
|
Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients |
| |
JL Murray, ES Kleinerman, JE Cunningham, JR Tatom, K Andrejcio, J Lepe-Zuniga, LM Lamki, MG Rosenblum, H Frost, and JU Gutterman |
| |
JCO Dec 1 1989: 1915–1925.
[Abstract]
[PDF]
|
|
|
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases |
| |
JH Turner, PG Claringbold, EL Hetherington, P Sorby, and AA Martindale |
| |
JCO Dec 1 1989: 1926–1931.
[Abstract]
[PDF]
|
|
|
Immunotoxins: a clinical review of their use in the treatment of malignancies |
| |
AA Hertler and AE Frankel |
| |
JCO Dec 1 1989: 1932–1942.
[Abstract]
[PDF]
|
|
| Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins |
| DW Acheson and A Donohue-Rolfe |
|
JCO Dec 1 1989: 1943.
[PDF]
|
|
